Polychlorinated biphenyls (PCBs) are lipophilic industrial compounds that show high chemical and thermal stability. Degradation in biological systems is low, and PCBs accumulate in food chains. Because of these properties and due to continued release from diffuse sources, like landfills and buildings with PCB-containing sealants, PCBs are still found in environmental samples, although their production and use were terminated in most countries 20-25 years ago. Unintended contamination of chemical products as in the production process of color pigments used in paints, inks, leather, plastics, textiles, cosmetics, and food contributes to ongoing exposure, at least in certain areas (Hu and Hornbuckle, 2010) . Exposure levels in the general human population have declined during the last years, but they are still relatively high in babies who ingest PCBs via breast milk from their mothers. For instance, the sum of PCB138, PCB153, and PCB180 measured 1.19 ng/ml serum in breast-fed babies compared with 0.25 ng/ml serum in bottle-fed babies (Lackmann et al., 2004) .
PCBs are known to affect several targets in the body, including prominent effects on the liver, immunoresponses, thyroid and reproductive hormone systems, as well as on the nervous system, in particular, during development. A number of studies indicate PCB-related influences on psychomotor and cognitive function in children (e.g., Boucher et al., 2009; Eubig et al., 2010; Stewart et al., 2008) . Among the neurotoxic effects, influences on the dopaminergic system and binding to ryanodine receptors are reported for various in vitro and in vivo experimental models (e.g., Dreiem et al., 2010; Fonnum and Mariussen, 2009; Pessah et al., 2006; Schantz et al., 1997) as well as humans . In addition, other neurotransmitter systems, like glutamatergic and GABAergic processes, appear to be involved (Altmann et al., 2001; Antunes Fernandes et al., 2010; Boix et al., 2010) . These neurochemical effects appear to be involved in physiological and behavioral impairments, including long-term potentiation (Altmann et al., 2001; Gilbert, 2003) , motor activity and habituation (Eriksson et al., 2006) , and different types of learning (Schantz and Widholm, 2001) . Also, effects on auditory function (Crofton et al., 2000) and sexually dimorphic behavior (Hany et al., 1999; Kaya et al., 2002) were reported. PCBs share several of these effects with other persistent halogenated compounds, like brominated flame retardants (BFRs) (Eriksson et al., 2001; Lilienthal et al., 2006) . Many of the changes induced by PCBs and BFRs are long lasting as they can be detected in adult animals after developmental exposure (Schantz and Widholm, 2001) . Several of the reported results of neurotoxicity in vitro have been ascribed to non-dioxin like (NDL) PCBs (Fischer et al., 1998) ; however, some effects in vivo can also be attributed to DL-PCBs (Schantz et al., 1996) . Neurophysiological and behavioral responses to DL-PCBs in vivo may also be mediated by effects on thyroid and steroid hormones, which are known to regulate development of the nervous system (e.g., Horn and Heuer, 2010; McCarthy, 2009) .
In general, the toxicological profile of DL-PCBs is well described, due to many studies related to tetrachlorodibenzop-dioxin and similar compounds that bind to the Ah receptor (e.g., Yoshizawa et al., 2007) . Accordingly, toxic equivalent factors have been assigned to these congeners (van den Berg et al., 2006) . In contrast, less systematic knowledge is available for NDL-PCBs, which form the majority of the 209 different PCB congeners. Most of the information about neurotoxicity of NDL-PCBs has been obtained in vitro (e.g., Kodavanti and Tilson, 1997; Pessah et al., 2006) , whereas the availability of data from in vivo or ex vivo models is limited to a few congeners and effects (e.g., Altmann et al., 1998; Boix et al., 2010; Eriksson and Fredriksson, 1996; Kenet et al., 2007; Piedrafita et al., 2008; Schantz et al., 1995 Schantz et al., , 1997 Seegal et al. 1990) . Therefore, the present experiments should expand our knowledge of neurobehavioral and physiological effects of NDL-PCB congeners in vivo after maternal exposure in rats. For this purpose, we tested if single ultrapure congeners that hitherto have received little attention in studies of developmental neurotoxicity affect some key targets of developmental PCB exposure. Because auditory effects are among the most consistent changes (e.g., Crofton et al., 2000; Kenet et al., 2007) of all PCB-induced effects described so far, we included brainstem auditory evoked potentials (BAEPs) as one of the outcome measures, aside from dopaminedependent and sexually dimorphic behavior, which will be described in a separate report. Auditory effects are also interesting because both technical PCB mixtures (Goldey et al., 1995) and the DL-PCB126 (Crofton and Rice, 1999) caused similar impairments of behaviorally determined hearing thresholds. As an indicator of auditory function, BAEPs are very stable responses to acoustical stimulation, with a proven sensitivity to developmental exposure to lead, to a PCB metabolite, and BFRs (Lilienthal et al., 2008 (Lilienthal et al., , 2009 Lilienthal and Winneke, 1996; Meerts et al., 2004) . In addition, effects on BAEPs are reported after developmental exposure to the technical PCB mixture Aroclor 1254 (e.g., Herr et al., 1996; Lasky et al., 2002) .
The present article describes BAEP effects of the NDLPCBs 2,2#,5,5#-tetraCB (PCB52) and 2,2#,3,4,4#,5,5#-heptaCB (PCB180) because both are frequently used to monitor environmental exposure in animals and humans (EFSA, 2005) . Also, both congeners exhibit different behavior in the environment, as PCB180 shows pronounced accumulation in food chains and is found at elevated levels in biological samples, in contrast to PCB52, which is metabolized more rapidly (Ö berg et al., 2002; Tanabe et al., 1981) .
MATERIALS AND METHODS
Chemicals. PCB52 and PCB180 were obtained from Chiron (Trondheim, Norway). The methods for purification of NDL-PCB congeners and analysis of TEQ purity (World Health Organization toxic equivalents; van den Berg et al., 2006) followed the methods described in Danielsson et al. (2008) . The purity of the PCBs was checked by dissolving 25 mg of the compound in hexane, which was eluted with 280 ml 1:1 n-hexane/dichloromethane on a 3-g charcoal carbon column (Andersson Fine Chemicals) mixed with celite (VWR International, France) (7.9/92.1). The column was turned upside down and eluted with 280 ml toluene. The toluene fraction was analyzed for DL-PCBs and polychlorinated dibenzo-p-dioxins and dibenzofurans using gas chromatography coupled with high-resolution mass spectrometry. These tests indicated that only trace levels of DL compounds were present in the purified NDL-PCB standards. The purity of the standards was determined to < 0.5 ng TEQ/g PCB52 and 2.7 ng TEQ/g PCB180. Purified PCBs were dissolved in corn oil (C8267 Sigma-Aldrich, batch: 065K0077), which was controlled for TEQ purity. No detectable TEQ was found in this corn oil (limit of detection < 0.1 pg TEQ/g oil).
Animals and treatments. Female and male Sprague Dawley rats were obtained from the breeder (Harlan, Zeist, The Netherlands) and housed in single stainless steel cages (floor size 1380 cm 2 ) at the animal house of THL (National Institute for Health and Welfare, Kuopio, Finland). Cages were supplied with a bedding of aspen chips (Tapvei Co., Kaavi, Finland). Rooms had a 12-h light:12-h dark cycle, with the light phase starting at 7 A.M. The ambient temperature was 21°C ± 2°C, and relative humidity was maintained at 50 ± 20%. Standard laboratory rodent diet (R36, Lactamin, Sweden) and water were available ad libitum. For mating, one female was transferred to the cage of one male. The morning of the day on which females were sperm-positive was taken as gestational day 0 (GD0). Thereafter, females were housed in single cages.
Pregnant females were randomly assigned to one of six dose groups (seven per group), which were orally exposed by gavage to PCB52 dissolved in corn oil, starting on GD7 and continued on every other day up to GD16. Dosing volume was 4 ml/kg body weight. Controls received only the vehicle. After delivery postnatal day 0 (PND0), dams received additional doses on every other day from PND1 to PND10. Thus, there were 10 applications in total. Total dose levels were 0, 30, 100, 300, 1000, or 3000 mg/kg body weight of PCB52. This wide dose range was chosen to allow benchmark analysis of the results, which requires a modeling of dose-response relation using the observed data (see ''Statistical Analysis''). Thus, a wide dose range needs to be examined for a reliable model. Body weights were determined in dams on GD0, followed by measurements during the dosing period and the day thereafter (PND11). All rats were daily examined for morbidity and mortality. Litters were standardized to 10 pups (5 males and 5 females) on PND1. Pup body weights were measured on PND1, PND4, and, then, once a week, starting on PND7. Offspring were weaned on PND28. After weaning, littermates of the same sex were housed together in one cage.
In general, the same procedures were followed in rats exposed to PCB180. However, dams received PCB180 daily from GD7 to GD10 (total dose of 0, 10, 30, 100, 300, 1000 mg/kg body weight), due to the longer half-life of PCB180 compared with PCB52, i.e., 81 to > 90 days versus 0.9-3.4 days, respectively (Ö berg et al., 2002; Tanabe et al., 1981) . Previous work from our group has demonstrated that, after prenatal treatment, exposure of pups via milk is higher than exposure across the placenta, at least for congeners with a long half-life, like PCB180 (Hany et al., 1999; Kaya et al., 2002; Lilienthal et al., 2000) . Details of the breeding procedures and maintenance of the offspring will be given in a separate report, together with results of reproductive outcome (Viluksela et al., in preparation) .
Seventy-nine rats exposed to PCB180 (39 males and 40 females) from the offspring were transferred to the animal house of IPA at Bochum, Germany, at PND80. Here, they were housed in same sex groups of four rats in Macrolon cages (size 59 3 38 3 20 cm, for L 3 W 3 H, respectively) with saw dust bedding (ssniff, Soest, Germany) and maintained on laboratory diet (RM-H, AUDITORY EFFECTS OF NON-DIOXIN LIKE PCBS 101 ssniff). The other housing conditions were the same as at THL. A second group of 85 rats (42 males and 43 females) exposed to PCB52 was transferred to IPA at the same age. There was an adaptation period of 4 weeks prior to the beginning of neurobehavioral and physiological measurements, which started with examination of sweet preference, followed by cataleptic behavior and, then, BAEP measurements. There were time intervals of at least 4 weeks between the end of one test and the beginning of next measurements to prevent serial effects.
All experimental procedures using rats were approved by the local German authorities on the basis of German legal regulations for animal studies (Landesamt für Natur, Umwelt und Verbraucherschutz, Nordrhein-Westafalen, Germany, AZ: 9.93.2.10.32.07.280). The protocol of breeding and exposure procedures used at National Institute for Health and Welfare (THL), Kuopio, Finland, were approved according to Finnish law by the Research Animal Use Committee, University of Kuopio (06-79 [19 July 2006] ).
BAEP recordings. Methods for recording of BAEPs followed the procedures described elsewhere (Lilienthal and Winneke, 1996; Lilienthal et al., 2009) . Briefly, BAEPs evoked by broadband clicks and frequencyspecific tone pips were recorded in 39 male and 38 female rats exposed to PCB52 and in 39 male and 38 female rats exposed to PCB180. Only in a few cases, more than one rat of the same sex was taken from one litter. This was taken into account when analyzing the results (see ''Statistical Analysis'' below). For BAEP recordings, rats were ip injected with a mixture of ketamine (males: 130 mg/kg body weight, females: 80 mg/kg body weight) and xylazine (males: 4.2 mg/kg body weight, females: 3.4 mg/kg body weight). Rats were placed on a heating pad during the measurements to prevent decreases in body temperature due to sedation. Platin/iridium needle electrodes (13L70, Dantec, Skovlunde, Denmark) were inserted under the skin on the vertex (active electrode) and behind the stimulated left ear (reference electrode). The ground electrode was inserted behind the right ear that was occluded with a tissue plug. Impedance of electrodes was usually below 1 kX, with no values higher than 2 kX accepted in all measurements. Experiments and extraction of raw data were conducted in blind fashion. Rats from different exposure groups were tested in varied sequences on each day of the BAEP recordings to avoid any effects of testing time and order.
BAEPs were recorded with a Dantec Keypoint workstation (Dantec). Sensitivity of the amplifier was set to 0.2 lV/division. High-and low-pass filters were set to 20 and 8000 Hz, respectively, to minimize distorting influences by analog filtering. Signals were digitized at an analog/digital rate of 204.8 kHz. The sweep duration was 10 ms. Auditory stimuli were delivered by an earphone inserted in the outer ear tube of the rat (Tubal Insert Earphone 31E27; Dantec). BAEPs were elicited with rarefaction clicks (duration of 50 ls) or tone pips of 0.5, 1, 2, 4, 8, and 16 kHz, starting with the rarefaction phase. Repetition rate of stimuli was 15 Hz for frequencies of 2-16 kHz and 10 Hz at 0.5 and 1 kHz. To determine BAEP thresholds, sound pressure level (SPL) of clicks and tone pips was varied from 80 dB (starting value) and then lowered in steps of 10 dB (clicks and tone pips of 0.5, 1, and 2 kHz) until the most prominent peak (wave II) could no longer be detected. Then, the SPL was increased by 5 dB to examine whether this could reestablish the signal. The lowest SPL at which the BAEP was present was taken as the threshold. For each BAEP, 300-1000 sweeps were averaged, until the signal stabilized. This means that averaging was continued until the clear presence of the signal. When no signal could be detected, averaging was continued until the trace obviously flattened in the last 100 sweeps, thus, indicating that no BAEP could be recorded at this condition. Presence of wave II was further verified by splitting the BAEP signal into two averages of odd and even sweeps, respectively. If wave II could be recognized in both traces, presence was noted. When background noise level in the signal was too high to allow a doubtless verification of presence, post hoc digital filtering between 100 and 3000 Hz of signals was used for unambiguous detection of wave II. The amplitudes of wave II at the threshold level were within 0.12-0.20 lV and 0.18-0.25 lV in males and females, respectively. In general, the same procedures were followed for threshold determinations at 4, 8, and 16 kHz, with the exception that the first lower SPL after 80 dB was 60, 40, and 50 dB, respectively because previous experiments had shown that the BAEP was present at these conditions in almost all rats. If not, the SPL was raised in steps of 5 dB, until the signal appeared. The same procedure was followed if no BAEP could be detected at 80 dB. Latencies of waves II and IV were determined as peak latencies from the onset of auditory stimuli in signals evoked by clicks at 80, 70, and 60 dB and by tone pips at 80 dB. Because latencies were recorded in suprathreshold BAEPs, averaging was continued until no changes could be detected in the last 100 sweeps, thus indicating that further averaging would not add any information. However, a minimum of 300 sweeps in total was recorded even at the most favorable conditions (8 and 16 kHz).
Statistical analysis. In a few cases, two rats of the same sex were taken from the same litter. For PCB52, there were three cases in control males and one in control females as well as three cases in males and four in females of the top dose group (3000 mg/kg). For PCB180, there was one case in males and another one in females of the top dose group (1000 mg/kg). These replications were preplanned before the BAEP test series and should ensure that values are robust in groups with only a few litters available or, in controls, to obtain a solid basis for the dose-response curve. Because there were only few occurrences, means were taken across two pups of the same sex, when taken from the same litter, to render a litter-based statistics. Thus, the actual statistical N was 33 males and 33 females in the PCB52 part (n ¼ 4-6/per sex and group) and 38 males and 37 females (n ¼ 5-7/per sex and group) in the PCB180 part of the experiment. The SAS Statistical Software (version 9.2; SAS Institute, Cary, NC) was used for statistical analyses. Results were evaluated by preplanned analyses of linear, quadratic, and cubic contrasts with the general linear models procedure, separately for each sex, to test for significant doseresponse relations, following analysis of general sex differences as a withinlitter factor. The significance level was set to a < 0.05. Benchmark modeling was used to determine dose levels at which deviations from control values exceeded a criterion value, the critical benchmark response (critical effect size [CES] ). Procedures of benchmark calculations are described in detail elsewhere (Slob, 2002; van der Ven et al., 2006) . Briefly, the PROAST software was used to model dose-response relation (http://www.rivm.nl/en/foodnutritionandwater/ foodsafety/proast.jsp). Observed BAEP data were fitted to the dose-response model giving the best fit at a significance level of a < 0.05. The dose-response model that described the data optimally was selected from a hierarchical family of models, by testing the likelihood of incremental complexity (increasing numbers of model parameters), according to Slob (2002) . Both sexes were included in benchmark analyses and tested for differences in dose-response relations as described by Slob (2002) . The CES for changes in the BAEP was set to 5% based on assumptions of biological significance of deviations from control level (see ''Discussion''). Precise temporal processing of auditory stimuli is crucial for higher-order capabilities, like sound localization in freeranging animals and speech perception in humans, which together with SPL differences between both ears, rely on the proper discrimination of interaural time differences (e.g., McAlpine, 2005) and phases (e.g., Rance, 2005) . The benchmark dose (critical effect dose [CED] ) and the lower 5% confidence limit (CEDL) were calculated from the model of the dose-response curve for a given parameter. To exclude results with a high statistical variation, a CED/CEDL ratio of 10 was used as a criterion of reliability. In the graphical examples of benchmark models, an approximation of the control dose level was used because of the logarithmic scale. However, the dose of 0 mg/kg body weight was used in the calculations.
RESULTS

General Development and Thyroid Hormones
Details of general developmental effects of PCB52 and PCB180 as well as thyroid hormone concentrations will be given in separate reports (Viluksela et al., in preparation) . Briefly, exposure to PCB52 did not affect maternal body weight. There were also no effects on 102 LILIENTHAL ET AL. body weights and mortality in the exposed offspring. Developmental milestones like eye opening, tooth eruption, and markers of sexual development were not altered, either. Free triiodothyronine (T3), but not free thyroxine (T4), was slightly decreased in serum from dams at doses of 100 mg/kg (p < 0.05). In addition, there were moderate decreases in circulating free T3 at doses of 30 mg/kg in male offspring and of 100 mg/kg in female offspring on PND35 (p < 0.05). Free T4 was slightly reduced only in female pups at higher levels of exposure ( 300 mg/kg; p < 0.05). Reduction in free T3 concentrations was also detected on PND84 (p < 0.05), whereas free T4 had normalized by this age.
PCB180 caused slight decreases in maternal body weight only at the top dose (1000 mg/kg). Pups from the same dose group also exhibited reduced body weights, but these were transient and normalized after the first week of life. Neonatal mortality was slightly increased at the two highest dose levels (300 or 1000 mg/kg). Markers of general development were not affected by PCB180, whereas slight delays of sexual development were observed. Circulating free T4 was not altered by exposure in dams and offspring. Free T3 was only slightly reduced in dams at dose levels 30 mg/kg (p < 0.05). There were no effects on free T3 in offspring on PND 35. In contrast, decreases in circulating free T3 were found at doses of 30 mg/ kg (males) and 100 mg/kg (females) on PND 84 (p < 0.05).
BAEP Thresholds
Representative BAEP traces are shown in Figure 1 . Statistical analysis revealed significant general differences between male and female offspring after developmental exposure to PCB52 (p ¼ 0.0068). Effects induced by PCB52
were somewhat more pronounced in male offspring, with threshold elevations up to 9 dB, compared with 7 dB in female offspring. In normal hearing subjects, an elevation of 9 dB corresponds to an increase in perceived loudness by 90%. Increases in BAEP thresholds were dose-dependent in both sexes in the frequency range from 0.5 to 8 kHz ( Figs. 2A and  2B) . According to the analysis of linear trends, dose-response relations were statistically significant at these frequencies (p < 0.05), with the exception of the threshold at 1 kHz in exposed females (0.05 < p < 0.1). Results of benchmark analyses are summarized in Table 1 , with representative results of benchmark modeling included in Figures 2C and 2D . Lowest CED and CEDL values were 166 and 50 mg/kg body weight, respectively (total dose). As shown in Table 1 , values are highest at 8 and 16 kHz, thus demonstrating decreasing sensitivity to PCB exposure at these frequencies.
Effects on BAEP thresholds were weaker after exposure to PCB180 during development (Figs. 3A and 3B ). There were significant differences between male and female offspring (p ¼ 0.0071). Significant linear dose-response relations were only found at 0.5 and 4 kHz in adult female offspring (p < 0.05). The difference in thresholds between control females and the highest dose group (1000 mg/kg) measured 5.6 dB at 4 kHz. Benchmark analysis revealed a corresponding CED of 449 mg/kg with a CEDL of 292 mg/kg (total dose). No significant doseresponse relations were detected in males (Fig. 3A) .
BAEP Latencies
In addition to threshold elevations, developmental exposure to PCB52 led to slight prolongation of latencies in male offspring. On the early wave II, latencies were increased in the 
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frequency range from 0.5 to 2 kHz, whereas latencies of the late wave IV were prolonged in the range of 0.5-8 kHz (Figs. 4A and 4C). The difference from controls to the highest exposure level (3000 mg/kg) measured 0.30 ms at the maximum on wave II compared with 0.13 ms in females. On wave IV, the maximum difference of the highest exposed group to controls was 0.44 ms in males and 0.35 ms in females. Effects on wave II latencies were not significant in females (p > 0.1; Fig. 4B ). In contrast, female wave IV was delayed in the frequency range of 0.5-2 kHz, but the dose-response relation was significant only at 2 kHz (p < 0.05; Fig. 4D) . A significant dose-response relation was also found for wave IV latency after stimulation with clicks at 60 dB, due to prolonged values in the 3000 mg group (mean [SEM]: controls 3.88 ms [0.14], 3000 mg group 4.36 ms [0.18]). The benchmark values shown in Table 1 for prolongation of latencies illustrate that effects were detected at higher dose levels compared with effects on BAEP thresholds, with CED and CEDL values between the two highest dose levels (1000 and 3000 mg/kg) in most cases.
There were no significant effects on latencies of wave II or wave IV after developmental exposure to PCB180 in males or females, with the exception of a significant dose-response relation for wave IV latency at 0.5 kHz in females (p < 0.05; see Supplementary data). When male and female offspring were analyzed together, minor effects were seen on wave II latency at 8 kHz and wave IV latency at the lowest click SPL (60 dB), with CED values close to the top dose (947-980 mg/kg) and corresponding CEDL values of 517 and 550 mg/kg (total dose), respectively.
DISCUSSION
The observed effects on the BAEP were detected in a general absence of exposure-related influences on developmental markers in PCB52 offspring. PCB180 resulted in slight alterations of neonatal body weights and mortality at higher dose levels. Both PCBs caused slight to moderate depression of circulating free T3. In PCB52 offspring, reduction was more expressed during the juvenile phase, whereas PCB180-induced reductions were found only in young adult rats. Several studies using exposure to technical PCB mixtures or DL-PCB congeners found more pronounced depression of thyroxine (T4) compared with T3 (e.g., Schantz and Widholm, 2001) , suggesting that the effect on T3 in our study may result from the use of ultrapure NDL-PCB congeners. Differential effects of DL-PCBs and NDL-PCBs on thyroid hormone-metabolizing enzymes in the liver and circulating thyroid hormone concentrations were described in previous studies (e.g., Martin and Klaassen, 2010) .
Exposure to PCB52 caused dose-related effects on the BAEP in male offspring. In contrast to its slightly more expressed developmental effects, PCB180 exerted smaller effects on BAEP thresholds than PCB52 in female offspring, with no significant auditory changes in male rats. This is illustrated by the benchmark doses, which were lower in females exposed to PCB52 compared with PCB180 females.
The elevated BAEP thresholds observed in adult offspring following developmental exposure to PCB52 are in general accordance with studies of BAEP thresholds in rats exposed to other polyhalogenated compounds, like hexachlorobenzene (Hadjab et al., 2004) or the flame retardants tetrabromobisphenol A (TBBPA) and hexabromocyclododecane (HBCD), which show similar effects on BAEP thresholds (Lilienthal et al., 2008 (Lilienthal et al., , 2009 ). PCB52 also led to prolonged latencies of waves II and IV in males, whereas only wave IV latency was increased in females. The prolongations seen in males were approximately the same for waves II and IV, indicating a cochlear site of action. One would expect more pronounced increases in wave IV compared with wave II if neurons of the ascending auditory pathway were affected, due to the increasing length of the conducting pathway. On the other hand, the increases in wave IV latencies seen in females cannot be simply the consequence of elevated thresholds because this should cause similar influences on all waves. Thus, an additional neural effect may be involved in the effects observed in females, becoming apparent only at later waves, in contrast to latency of the early wave II. Consistent with this, previous studies have revealed that different nuclei of the developing auditory brainstem and maturation of function in auditory neurons are affected in the presence of developmental disturbances, like hypothyroid conditions (Friauf et al., 2008; Guadano-Ferraz et al., 1999; see below) . Notably, all the effects seen on thresholds and latencies were more expressed at lower frequencies of the rat hearing curve. The present results correspond well to investigations of auditory function after exposure to technical PCB mixtures, using BAEPs (e.g., Herr et al., 1996; Lasky et al., 2002) or behavioral methods (Goldey et al., 1995) . The latter authors reported increased hearing thresholds determined with auditory startle inhibition after developmental exposure to Aroclor 1254. The effects were most pronounced at the low frequency of 1 kHz and could be related to a mild or moderate loss of outer hair cells in the upper-middle and apical turn of the cochlea (Crofton et al., 2000) . In the study by Herr et al. (1996) , decreased amplitudes were found in the BAEP of PCBexposed rat offspring. This is in accordance with our results because decreased amplitudes at above-threshold levels result in an elevation of the lowest SPL at which the BAEP can be detected. The elevations indicate concomitant increases in hearing thresholds as a close correspondence of electrophysiological and behavioral thresholds has been noted already in early investigations, with several recent confirmations (e.g., Wolski et al., 2003) . The lesser sensitivity of BAEP latencies compared with thresholds is also supported by a previous study (Herr et al., 1996) in which prolonged latencies were detected only at the highest dose level of Aroclor 1254 and only at the lowest frequency used (1kHz).
The similarity of the pattern of auditory effects following perinatal exposure to the NDL-PCB52 described here with results of treatment with technical mixtures (Goldey et al., 1995) and even the coplanar congener PCB126 (3,3#,4,4#,5-pentaCB; Crofton and Rice, 1999 ) is remarkable. It either precludes an Ah receptor-mediated response by PCB mixtures and DL-PCBs on auditory function or indicates different modes of action, which eventually lead to similar effects of DL-PCBs and NDL-PCBs on the developing cochlea by convergence to the same molecular target, which in turn induces the observed auditory deficit. Thyroid hormones could constitute such a factor, as suggested by Goldey et al. (1995) , who attributed observed hearing impairments to reduced serum concentrations of thyroid hormones. This conclusion was supported by demonstrating that thyroxine replacement resulted in a partial amelioration of the hearing deficit in PCB-exposed rats (Goldey and Crofton, 1998 ). Our results demonstrate impairment of auditory function with concomitant decreases in circulating free T3, which is generated by deiodinases from T4.
The importance of sufficient supply with thyroid hormones for auditory development has been delineated in a number of reports. Lack of thyroid hormones results in impairment of several processes in the developing inner ear, including differentiation of the sensory epithelium, formation of the tectorial membrane, and expression of the motor protein prestin in outer hair cells needed for rapid longitudinal changes in response to sound (recent reviews, e.g., Bianchi and Fuchs, 2010; Bryant et al., 2002; Forrest et al., 2002) . Also, a compromised endocochlear potential, impaired development of the stria vascularis, and delayed maturation of fast calcium and potassium conductance in inner hair cells have been found following disturbed thyroid hormone function (Brandt et al., 2007; Mustapha et al., 2009) , in addition to effects on neurons in the auditory pathway (e.g., Friauf et al., 2008) . However, it remains unresolved from our data whether the auditory impairment described here can be attributed only to reductions in circulating free T3. Generally, it has been argued that circulating concentrations of thyroid hormones are not a good indicator of compromised thyroid hormone function (reviewed in Zoeller, 2010) . In accordance with this, recent results demonstrated dissociation between decreased circulating thyroid hormones and auditory effects of polybrominated diphenyl ethers (Poon et al., 2010) . Also, effects on BAEPs in rats with lifetime exposure to HBCD show little evidence for a causal relation to circulating thyroid hormones (Lilienthal et al., 2009) . However, PCBs may also directly affect thyroid hormone receptors, transporters, deiodinases, and hormonebinding proteins, all of which have been demonstrated to have their role in development of the inner ear (e.g., Ng et al. 2009; Suzuki et al. 2007; Winter et al. 2006) .
In addition to thyroid hormones, several other factors are involved in development of the cochlea, which is plausible because of its complex structure. For instance, an FIG. 4 . BAEP latencies in rats exposed to PCB52. (A) Wave II, males, (B) wave II, females, (C) wave IV, males, and (D) wave IV, females. All groups are shown in panel (A) to demonstrate that prolongation was observed in both top dose groups; asterisk indicates significant dose-response relation for prolongation of latencies (p < 0.05); means ± SE; n ¼ 4-6/sex/group.
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antagonist of the retinoic acid receptor, reduced the number of cells that undergo final differentiation to hair cells in cultures of the embryonic cochlea (Raz and Kelly, 1999) . Interactions between PCBs and retinoids have been noted in several reports (e.g., Chen et al., 1992; Mos et al., 2007) . PCBs may also interfere with inner cochlear development through ryanodine receptor isoforms, which have been shown to be present in the developing rat cochlea with an increase in expression from PND5 onwards (Liang et al., 2009) . These receptors are involved in Ca signaling and are differentially expressed in the adult cochlea (Grant et al., 2006; Morton-Jones et al., 2006) . PCB52 and PCB180 exhibit different potencies to activate ryanodine receptor RyR1 (Pessah et al., 2006; Rayne and Forest, 2010) . The EC 2x (the concentration needed to increase activation by twofold) and EC 50 values of PCB180 were~1 and 2.6 lM, respectively and, thus, by a factor of two higher than the corresponding values of PCB52 (Pessah et al., 2006) . Consequently, developmental exposure to these congeners may differentially activate ryanodine receptors, resulting in stronger effects of PCB52 as compared with PCB180 on auditory function. On the other hand, a recent report failed to demonstrate effects of perinatal exposure to PCB95, the most potent congener for RyR1 activation, on the BAEP, whereas exposure-induced changes were detected in the structural and functional organization of the auditory cortex (Kenet et al., 2007) . The only dose level used (6 mg/kg body weight/ day-total dose: 234 mg/kg) was within the range of the CEDL values obtained in the present experiments. Thus, there is little evidence that ryanodine receptor activation accounts for the PCB52-related auditory deficit. A study of PCB-induced changes in expression and function of ryanodine receptors in the developing inner ear might be useful to clarify whether the detected auditory impairment is mediated by ryanodine receptors and how this can explain frequency-dependent effects.
The observation of stronger effects of developmental PCB exposure on BAEP thresholds in the low-frequency range of the hearing curve corresponds to previous results obtained with technical mixtures cited above, showing impaired auditory function (Goldey et al., 1995) and loss of hair cells in the uppermiddle and apical turns of the cochlea (Crofton et al., 2000) . The reasons for this frequency selectivity are not well understood. It is well known that there is a gradient from high-frequency sound processing in the basal cochlea to low-frequency processing in the apical cochlea. Cochlear development proceeds from basal to apical turns in mammals, including humans and rodents. However, the first functional responses to sound are detected at low frequencies (reviewed, e.g., in Bianchi and Fuchs, 2010) . This discrepancy was resolved by experiments, showing that the region of responses to low-frequency sound shifts from the basal to the apical turns of the cochlea during development (Müller, 1991; Rubel and Ryals, 1983; Yancey and Dallos, 1985) . In the rat, the difference of initial auditory thresholds to adult thresholds is smaller at lower frequencies at the onset of hearing on PND11-12, after which sensitivity to higher frequencies rapidly improves, so that mature responses of auditory nerve fibers are found at high frequencies earlier than at low frequencies (Puel and Uziel, 1987) . Furthermore, tuning of auditory nerve fibers, which accounts for frequency selectivity, matures earlier at lower compared with higher frequencies (Puel and Uziel, 1987) . Thus, the selective impairment of low-frequency processing by PCBs suggests an interference with auditory development in the early postnatal phase to solely affect auditory processing at lower frequencies. This conclusion is further supported by the observation that the BAEP to bone-conducted sound can already be recorded on PND7, which is 4 days before responses can be detected to air-middle ear conducted acoustic stimuli (Geal-Dor et al., 1993) , so that interference by PCBs with inner ear development is likely to occur within the first postnatal week. In recent reports, spontaneous activity was described in inner hair cells and neurons of the auditory nerve and brainstem in rodents before the onset of hearing airborne sound (e.g., Sonntag et al., 2009; Tritsch et al., 2007 Tritsch et al., , 2010 . This premature activity is assumed to promote the formation and maintenance of tonotopy in auditory structures (Tritsch et al., 2010) . Thus, it may be worth to examine if perinatal PCB exposure affects these early events in development of the auditory system.
The maximum threshold elevations of 9 dB for PCB52 and of 6 dB for PCB180 may seem small compared with clinical hearing impairment, but an elevation of 9 dB means that sound intensity at the threshold in control rats must be increased more than eightfold to reach the threshold in exposed subjects. Normal hearing human subjects would experience this difference as an increase by 90% in perceived loudness (Rossing, 1990) . However, thresholds were increased to this extent only at the highest dose level, indicating that the potency of PCB52 (and also of PCB180) to affect auditory function is limited compared with technical mixtures (Crofton et al., 2000) . The more pronounced effects of PCB mixtures may result from a contribution of DL-PCBs, which are present in technical mixtures and environmental samples (e.g., Kodavanti et al., 2001) . Interestingly, PCB-related auditory deficits were also detected in exposed children (e.g., Trnovec et al., 2010) . It has been suggested that impaired auditory processing in human children leads to subtle speech perception problems, leading to deficits in phonological skills and reading development (Boets et al., 2007) . It is well known that speech perception depends on the proper discrimination of phases (Rance, 2005) . Also, sound localization may be compromised in free-ranging animals, as it relies on the precise processing of interaural time and level differences (McAlpine, 2005) . Because of the importance of subtle impairments of these auditory functions in humans and animals, a benchmark response of 5% was selected in this study, in contrast to studies of hearing loss induced by co-exposure to noise and chemicals which used a criterion of 10% (e.g., Fechter, 2004) .
The lowest CEDL value determined in our study was 50 mg/kg body weight for the total dose. When comparing the total dose levels used in the present study with the total PCB intake in 108 LILIENTHAL ET AL.
humans, one has to take into account that human mothers and children are not only exposed to one congener, in this case PCB52, but to several other NDL-PCBs that may induce similar effects on the auditory system. Also, kinetic differences must be considered because the metabolic rate is much higher in smaller mammals compared with human beings (Calabrese, 1983) . The reported half-life of PCB52 and PCB 180 are 0.9-3.4 days and 83 to > 90 days, respectively, in rats (Ö berg et al., 2002; Tanabe et al., 1981) , whereas values of 5.5 years and 4.8-9.9 years were determined for PCB52 and PCB180, respectively, in humans (Ryan et al., 1993; Wolff et al., 1992) . The increasing amount of available data collected on a number of NDL-PCBs in the recent research project ATHON (Assessing the toxicity and hazard of NDL-PCBs present in Food-www.athon-net.eu) of which the present experiment is a part is expected, together with other investigations, to provide a more solid basis for extrapolation of experimental findings to possible human risks.
CONCLUSIONS
Taken together, our findings confirm that ultrapure NDLPCBs induce similar auditory effects as technical mixtures and DL-PCB congeners. Our results further demonstrate that different NDL-PCBs exhibit different potencies to affect auditory function. Therefore, their toxicity profiles are likely to be different, as also suggested by our data on catalepsy and sexually dimorphic behavior.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci. oxfordjournals.org/. 
